American Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
nCino
NCNO
|
+$15.2M |
| 2 |
Globus Medical
GMED
|
+$12.2M |
| 3 |
NeoGenomics
NEO
|
+$7.92M |
| 4 |
Azenta
AZTA
|
+$951K |
| 5 |
Graham Corp
GHM
|
+$614K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AeroVironment
AVAV
|
+$32.2M |
| 2 |
CYBR
CyberArk
CYBR
|
+$29.5M |
| 3 |
Gentex
GNTX
|
+$28.2M |
| 4 |
Fortinet
FTNT
|
+$27.8M |
| 5 |
Cognex
CGNX
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.84% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 18.81% |
| 4 | Financials | 7.69% |
| 5 | Real Estate | 2.65% |
Similar funds
American Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, American Capital Management held 65 positions worth $2.41B, down 1.9% from $2.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
American Capital Management withdrew a net $409M in Q2 2025, closing 2 positions and reducing 41 holdings. Its most notable exit was Charles River Laboratories, an estimated $4.18M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, American Capital Management opened a new position in VSE Corp worth $583K.
- American Capital Management's largest Q2 2025 buy was VSE Corp: 4,453 shares worth $583K.
- American Capital Management added most to nCino in Q2 2025, an estimated $15.2M increase.
- American Capital Management's biggest Q2 2025 reduction was AeroVironment, cutting an estimated $32.2M.
- American Capital Management fully exited Charles River Laboratories in Q2 2025, selling an estimated $4.18M.
- American Capital Management's ten largest holdings make up 47% of its $2.41B portfolio in Q2 2025.
- American Capital Management opened 2 new positions and closed 2 in Q2 2025.
- American Capital Management's portfolio value fell 1.9% quarter-over-quarter to $2.41B.
Based on American Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.